Strong Memorial Hospital is an 886-bed medical facility, part of the University of Rochester Medical Center complex, in Rochester, New York. Opened in 1926, it is a major provider of both in-patient and out-patient medical services.

There are 886 beds in Strong Memorial Hospital.

During the past decade, Strong Memorial Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 26 clinical trials were completed, i.e. on average, 81.3% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 11 clinical trials were completed. i.e. 73.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Strong Memorial Hospital" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 18 trials, followed by "University of Rochester" with 13 trials sponsored, "Boston Scientific Corporation" with 9 trials sponsored, "Cornell University" with 3 trials sponsored and "University of Michigan" with 3 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Strong Memorial Hospital" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 12 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator, "Medical University of South Carolina" with 5 trials as a collaborator, "Cystic Fibrosis Foundation" with 4 trials as a collaborator and "Merck Sharp & Dohme LLC" with 3 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Strong Memorial Hospital" are "HIV Infections" (20 trials), "Stroke" (5 trials), "Cystic Fibrosis" (4 trials), "Heart Failure" (4 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Strong Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Strong Memorial Hospital" are "Drug" (40 trials), "Device" (25 trials), "Biological" (18 trials), "Other" (9 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Standard of Care" (3 trials), "Apixaban" (2 trials), "Aspirin" (2 trials) and "Pneumococcal Conjugate Vaccine, Heptavalent" (2 trials). Other intervention names were less common.

The vast majority of trials in "Strong Memorial Hospital" are 94 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Strong Memorial Hospital". undefined are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 70 completed trials in Strong Memorial Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Strong Memorial Hospital, 14 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 31 trials that are defined as “Not Applicable".